163 related articles for article (PubMed ID: 16546667)
1. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.
Kraus S; Naor Z; Seger R
Cancer Lett; 2006 Mar; 234(2):109-23. PubMed ID: 16546667
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
3. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
Harrison GS; Wierman ME; Nett TM; Glode LM
Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues.
Cheung LW; Wong AS
FEBS J; 2008 Nov; 275(22):5479-95. PubMed ID: 18959738
[TBL] [Abstract][Full Text] [Related]
7. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
Naor Z
Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
So WK; Cheng JC; Poon SL; Leung PC
FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
10. Elevated GnRH receptor expression plus GnRH agonist treatment inhibits the growth of a subset of papillomavirus 18-immortalized human prostate cells.
Morgan K; Stavrou E; Leighton SP; Miller N; Sellar R; Millar RP
Prostate; 2011 Jun; 71(9):915-28. PubMed ID: 21541969
[TBL] [Abstract][Full Text] [Related]
11. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes.
Hapgood JP; Sadie H; van Biljon W; Ronacher K
J Neuroendocrinol; 2005 Oct; 17(10):619-38. PubMed ID: 16159375
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
[TBL] [Abstract][Full Text] [Related]
14. GnRH receptor and androgen receptor status and outcome of advanced prostate carcinomas.
Szabó J; Bartók K; Krenács T; Szepesváry Z; Szende B
Anticancer Res; 2009 Feb; 29(2):681-4. PubMed ID: 19331222
[TBL] [Abstract][Full Text] [Related]
15. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
17. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes.
Rothman MS; Wierman ME
Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):306-10. PubMed ID: 17940457
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
Alberti C
Eur Rev Med Pharmacol Sci; 2007; 11(1):59-64. PubMed ID: 17405349
[TBL] [Abstract][Full Text] [Related]
19. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
20. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
